It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Data reveals potential for once-daily oral and monthly injectable treatment alternatives for patients with type 2 diabetes and obesity CHICAGO, June 23, ...

The report spotlights China’s rapid biopharma advancement, alongside a GLP-1 surge, caution surrounding M&A, and a rise in ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

The blockbuster weight loss drug, semaglutide, now has competition in orforglipron, which is just as safe as injectable ...

The IDF continues its efforts to degrade the Iranian Regime's military capabilities, it said in a post on Telegram ...

It was 96 degrees in the air and much, much hotter on track at Road America as Alex Palou won the XPEL Grand Prix during an ...

Attendees might be looking to wean off weight-loss drugs or mitigate side effects such as digestive discomfort and muscle ...

India and England will renew their rivalry and lock horns in the first Test of the five-match series in Leeds from June 20 to ...

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite ...